International Isotopes (INIS) Stock Price, News & Analysis

Company Overview

International Isotopes Inc. manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, and radiopharmaceutical and radiochemical contract manufacturing services in the United States and internationally. It operates through four segments: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, and Fluorine Products. The Nuclear Medicine Standards segment manufactures sources and standards associated with single photon emission computed and positron emission tomography imaging, patient positioning, and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry. This segment also offers flood sources, dose calibrators, rod sources, flexible and rigid rulers, spot and pen point markers, and various specialty design items. The Cobalt Products segment produces bulk cobalt; fabricates cobalt capsules for radiation therapy and various industrial applications; and recycles expended cobalt sources. The Radiochemical Products segment produces and distributes various isotopically pure radiochemicals and sodium iodide I-131 generic drug product for medical, industrial, and research applications. The Fluorine Products segment is involved in the production of small-scale qualification samples of high purity fluoride gas for various industrial applications, as well as development of laboratory and analytical processes required to support the planned uranium de-conversion and fluorine extraction facility. The company sells its products directly to end users and distributors. International Isotopes Inc. was incorporated in 1995 and is headquartered in Idaho Falls, Idaho.

Key Stats

• Today's Range: $0.04 to $0.05
• 50-Day Range: $0.03 to $0.05
• 52-Week Range: $0.02 to $0.06
• Volume: 5,900 shs
• Average Volume: 127,801 shs
• Market Capitalization: $22.52 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

International Isotopes Stock Analysis - MarketRank™

International Isotopes scored higher than 3% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for International Isotopes.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

International Isotopes has a P/B Ratio of 4.30. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.00% of the outstanding shares of International Isotopes have been sold short.

Short Interest Ratio / Days to Cover

International Isotopes has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in International Isotopes has recently increased by 645.45%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

International Isotopes does not currently pay a dividend.

Dividend Growth

International Isotopes does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.00% of the outstanding shares of International Isotopes have been sold short.

Short Interest Ratio / Days to Cover

International Isotopes has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in International Isotopes has recently increased by 645.45%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

News Sentiment

International Isotopes has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Computer and Technology companies.

News Coverage This Week

MarketBeat has tracked 1 news article for International Isotopes this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, International Isotopes insiders have not sold or bought any company stock.

Percentage Held by Insiders

15.60% of the stock of International Isotopes is held by insiders. A high percentage of insider ownership can be a sign of company health.

INIS Stock Analysis - Frequently Asked Questions

How have INIS shares performed this year?

International Isotopes' stock was trading at $0.0344 at the beginning of the year. Since then, INIS shares have increased by 25.0% and is now trading at $0.0430.
View the best growth stocks for 2025 here.

How were International Isotopes' earnings last quarter?

International Isotopes Inc. (OTCMKTS:INIS) released its earnings results on Monday, April, 2nd. The technology company reported $0.00 earnings per share for the quarter. The technology company earned $1.90 million during the quarter. International Isotopes had a negative net margin of 2.63% and a negative trailing twelve-month return on equity of 8.68%.

How do I buy shares of International Isotopes?

Shares of INIS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of International Isotopes own?

Based on aggregate information from My MarketBeat watchlists, some other companies that International Isotopes investors own include Chembio Diagnostics (CEMI), Prospect Capital (PSEC), Calumet Specialty Products Partners (CLMT), Two Harbors Investment (TWO), BlackRock Capital Investment (BKCC), NovoCure (NVCR) and Summit Midstream Partners (SMLP).

Company Calendar

• Last Earnings: 4/02/2018
• Today: 2/05/2025
• Next Earnings (Estimated): 3/27/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Computer and Technology
• Industry: Process control instruments
• Sub-Industry: Measuring And Control Equipment
• Current Symbol: OTCMKTS:INIS
• CUSIP: N/A
• CIK: 1038277
• Web: www.intisoid.com
• Phone: (208) 524-5300
• Fax: 208-524-1411
• Employees: 30
• Year Founded: 1995

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-870,000.00
• Net Margins: -2.63%
• Pretax Margin: -2.63%
• Return on Equity: -8.68%
• Return on Assets: -2.09%

Debt

• Debt-to-Equity Ratio: 0.44
• Current Ratio: 1.58
• Quick Ratio: 1.33

Sales & Book Value

• Annual Sales: $12.27 million
• Price / Sales: 1.84
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.01 per share
• Price / Book: 4.30

Miscellaneous

• Outstanding Shares: 523,710,000
• Free Float: 442,008,000
• Market Cap: $22.52 million
• Optionable: Not Optionable
• Beta: 0.52